support online
Hepatitis C-virus (HCV)
Zoeken op naam:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Ð
  • Copegus
    $5.04
    Copegus
    Ribavirin
    Copegus is used to treat chronic hepatitis C which is a disease of the liver. It helps the ...
    NU KOPEN
  • Daclatasvir
    $16.30
    Daclatasvir
    Daclatasvir
    Daclatasvir is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying ...
    NU KOPEN
  • Daklinza
    $16.30
    Daklinza
    Daclatasvir
    Daklinza (daclatasvir) is an antiviral medicine that prevents hepatitis C virus (HCV) from ...
    NU KOPEN
  • Harvoni
    $10.09
    Harvoni
    Ledipasvir / Saofosbuvir
    Generic Harvoni is an antiviral medication used to treat hepatitis C (Hep C). Generic Harvoni ...
    NU KOPEN
  • Sofosbuvir
    $34.37
    Sofosbuvir
    Sofosbuvir
    Sofosbuvir is an antiviral medication that prevents hepatitis C virus (HCV) from multiplying ...
    NU KOPEN
  • Sovaldi
    $34.37
    Sovaldi
    Sofosbuvir
    Generic Sovaldi (Sofosbuvir) is an antiviral medication that prevents hepatitis C virus (HCV) ...
    NU KOPEN
Getuigenissen
Geoffrey, Rolling Meadows
My apologies. I did not know the items were sent separately. I received the second envelope yesterday. Thank you for your help and support.
Payton, Perth
“Honeymoon returned and my husband feels like a teenager again. His erection is the same as at our first date 30 years ago. He feels like a man again, his penis is hard with a big ...
Nieuws
Price of Mounjaro to be discounted in UK pharmacies
The rebate allays fears of a 170% price rise but patients are warned the cost of the drug will still jump.
NHS to lose out on new drugs, pharma firm warns
The claims from pharmaceutical giant Novartis comes amid a row over drug pricing deals.
Patients struggle to get weight loss drug ahead of price rise
The drug's US manufacturer has asked UK distributors to stop taking orders from pharmacies until next month's price increase.
Seven-week wait for some red flag cancer patients 'frustrating'
The target set by the Department of Health for patients red flagged for breast cancer to be assessed is 14 days.